Senior insider sale
Chief Scientific Officer at FULGENT GENETICS, INC. — senior position signals high conviction
$98.1K
3.61K shares
What this filing means
GAO HANLIN plans to sell 3.61K shares of FULGENT GENETICS, INC. valued at approximately $98.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/1/2025ACC: 0001193125-25-304290
Officer· Chief Scientific Officer
Since Feb 2026
3.61K
Shares to sell
$98.1K
Approx. market value
32K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted stock vest
Equity compensation for services rendered
2/28/2022
32KTotal acquired32K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/28/2022 | Restricted stock vest Equity compensation for services rendered | 32K | — |
| Total | 32K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
943.00
Market value
$27.9K
11/28/2025
—Completed
Units to sell
535.00
Market value
$16.3K
11/24/2025
—Completed
Units to sell
1.06K
Market value
$23.4K
9/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.07K
Market value
$30.5K
12/2/2025
Total
Units
3.61K
Value
$98.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/28/2025 | 943.00 | $27.9K | — | Completed |
11/24/2025 | 535.00 | $16.3K | — | Completed |
9/3/2025 | 1.06K | $23.4K | — | Completed |
| Planned — Approximate Date | ||||
12/2/2025 | 1.07K | $30.5K | NASDAQ | Planned |
| Total | 3.61K | $98.1K | ||